Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.
Daniel Anderson, PharmD
Advertisement
Articles by Daniel Anderson, PharmD
Advertisement
Latest Updated Articles
- Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections
Published: August 20th 2020 | Updated:
Advertisement
Advertisement
